AstraZeneca Plc's Enhertu approved in the US for HER2+ solid

AstraZeneca plc and Daiichi Sankyo's Enhertu has gained US approval for treating HER2-positive solid tumours, marking a significant advancement in cancer treatment.

Related Keywords

Brazil , Australia , Texas , United States , Singapore , Ken Keller , Dave Fredrickson , Daiichi Sankyo , University Of Texas Md Anderson Cancer Center , Daiichi Sankyo Inc , Astrazeneca , Drug Administration , Investigational Cancer Therapeutics , Cancer Center , Executive Vice President , Oncology Business Unit , Global Head , Oncology Business , Practice Guidelines , Time Oncology Review , Priority Review , Breakthrough Therapy Designation , Project Orbis ,